Wright Bonilla Discusses Gene Patents
14 November 2010
BioCentury This Week
News
Foley Partner Jacqueline Wright Bonilla appeared in a video segment published to BioCentury This Week on November 14, 2010 titled "Myriad Pro-Con." Wright Bonilla clarifies the definition of gene patents and makes the case for a company’s right to commercialize research and development that could lead to a diagnostic in a drug. She also discusses the Assn. for Molecular Pathology, et al. v. USPTO, et al. (ACLU v. Myriad) "gene patenting" case.
Related Services
Practice Areas
Insights
You Can’t Always Get What You Want: Funding Supply Not Meeting Startup Demands
02 February 2023
Foley Ignite
Proposed Amendments Schedule 13D - Part Two
01 February 2023
Foley Funds Legal Focus
Proposed Amendments Schedule 13D – Part One
01 February 2023
Foley Funds Legal Focus
Breathe Easy: U.S. EPA Seeks to Significantly Tighten Fine Particulate Matter Standards
01 February 2023
Manufacturing Industry Advisor
Foley Represents Mirantis in Acquisition of Shipa
02 February 2023
Natasha Allen Discusses Latest Government Guidance on AI Risk
01 February 2023
Bloomberg Law
Lauren Champaign Elected to the Interfaith Action for Human Rights Board of Directors
01 February 2023
Foley Named 2023 Legal Technology Trailblazer for Foley Equipped by National Law Journal
01 February 2023
DTC Healthcare Conference: How to Build and Scale a Multistate DTC Telemedicine Company
28 April 2023
New York
American Health Law Association’s Institute on Medicare and Medicaid Payment Issues 2023 Conference
23 March 2023
Baltimore, MD
2023 Mid-Atlantic Telehealth Resource Center (MATRC) Summit
15-17 March 2023
Norfolk, VA/Webinar
American Telemedicine Association ATA2023 Conference
4-6 March 2023
San Antonio, TX